Novartis Investigative Site

Sochaczew 96-500

0 studies enrolling now · 4 studies all time

What they study most

Ankylosing Spondylitis, Autoimmunity, Inflammation, Cardiovascular Disease and Lipoprotein(a), Psoriatic Arthritis

Studies at this site

• Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
• Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD — Running, not enrolling
• Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis — Completed
• Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA — Completed